1. Exarie JE, Tcheng JE, Kereakes DJ et al. Closure devices and vascular complication among percutaneous coronary intervention patients receiving enoxaparin, IIb/IIIa inhibitors and clopidogrel. Catheter Cardiovasc Interv 2005; 64: 369–72.
2. Krone RJ, Johnson L, Noto T. Five year trend in cardiac catheterization: A report from the Registry of the Society for Cardiac Angiography and Intervention. Cathet Cardiovasc Diagn 1996; 39: 31–5.
3. Dauerman et al. JACC 2007; 50: 1617–26.
4. Nikolsky E, Mehran R, Halkin A. Vascular complication associated with closure devices in patients undergoing percutaneous coronary procedure. J Am Coll Cardiol 2004; 44: 1200–9.
5. Assali AR, Stringola S, Maustapha A. Outcome of acces site in patients treated with IIb/IIIa inhibitors in the era of closure devices. Cath Cardiovasc Interv 2003; 58:1–5.
6. A randomized comparison a novel bioabsorbable vascular closure device versus manual compression in achievement of hemostasis after percutaneous femoral acces. J Am Coll Cardiol 2009; 2: 785–93.
Авторы
А.П.Савченко, О.В.Черкавская, Б.А.Руденко
Российский кардиологический научно-производственный комплекс, Москва